DDOG insider sale notice — 45,444 Class A shares via Morgan Stanley
Rhea-AI Filing Summary
Datadog, Inc. (DDOG) filed a Form 144 notifying of a proposed sale of 45,444 Class A common shares through Morgan Stanley Smith Barney LLC on or about 10/01/2025. The filing lists an aggregate market value of $6,471,225.60 based on 323,270,704 shares outstanding. The shares to be sold were acquired on 04/07/2021 through previously exercised stock options and paid for in cash on the same date. The filing also discloses related recent sales by the AGARWAL 2018 FAMILY TRUST: 44,444, 33,333, 10,094, and 18 Class A shares on 09/15/2025–09/18/2025, which generated gross proceeds of approximately $12,000,138.59. The notice includes the standard representation that the seller is not aware of undisclosed material adverse information.
Positive
- None.
Negative
- Form 144 reports planned disposal of 45,444 Class A common shares with an aggregate market value of $6,471,225.60.
- The filing discloses recent 10b5-1 sales by AGARWAL 2018 FAMILY TRUST totaling 87,889 shares on 09/15/2025–09/18/2025 with gross proceeds of approximately $12,000,138.59.
Insights
TL;DR: Form 144 shows a planned sale of 45,444 DDOG shares and substantial prior 10b5-1 sales by a related trust totaling 87,889 shares.
The filing documents a routine Rule 144 notice for the sale of 45,444 Class A shares via Morgan Stanley Smith Barney, acquired by exercise of options in April 2021 and paid in cash. The filing also transparently reports multiple 10b5-1 plan sales by the AGARWAL 2018 FAMILY TRUST between 09/15/2025 and 09/18/2025 totaling 87,889 shares and gross proceeds of approximately $12.0 million. This is disclosure of insider-affiliated selling activity rather than operating results; it allows market participants to see the volume and timing of planned sales.
TL;DR: The Form 144 provides compliant disclosure of insider-related sales and confirms use of a broker and 10b5-1 sales by a family trust.
The notice includes required statements about lack of undisclosed material information and cites a broker for execution. It also specifies the acquisition method (previously exercised options) and payment details, which supports regulatory transparency. The separate listing of recent 10b5-1 sales by the AGARWAL 2018 FAMILY TRUST documents executed transactions and gross proceeds, aiding governance oversight of insider dispositions.